Results 61 to 70 of about 13,816 (168)

Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans

Memorias do Instituto Oswaldo Cruz
BACKGROUND Infective endocarditis is a disease characterised by heart valve lesions, which exhibit extracellular matrix proteins that act as a physical barrier to prevent the passage of antimicrobial agents.
Gerardo Becerra Victorio, Lorena Michele Brennan Bourdon, Leonel García Benavides, Selene G Huerta-Olvera, Arturo Plascencia, José Villanueva, Erika Martinez-Lopez, Iván Isidro Hernández-Cañaveral   +7 more
doaj   +1 more source

Recurrent Candida albicans Ventriculitis Treated with Intraventricular Liposomal Amphotericin B

Case Reports in Infectious Diseases, 2015
Central nervous system (CNS) infection with Candida is rare but significant because of its high morbidity and mortality. When present, it is commonly seen among immunocompromised and hospitalized patients.
Demet Toprak, Sevliya Öcal Demir, Eda Kepenekli Kadayifci, Özden Türel, Ahmet Soysal, Mustafa Bakir   +5 more
doaj   +1 more source

Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox : A Case Report

Journal of Microbiology and Infectious Diseases, 2016
In this paper, we present a 69 years old diabetic patient with mucormycosis who was succesfully treated with liposomal amphotericin B (LAMB), posaconazole and deferasirox despite having no adequate surgery.
Uğur Onal, Meltem Taşbakan, Tansu Yamazhan, Bilgin Arda, Husnu Pullukcu, Sercan Ulusoy, Oğuz Reşat Sipahi   +6 more
doaj   +1 more source

Retrobulbar Injection of Amphotericin B in the Management of Acute Invasive Fungal Sino-Orbital Infections

B-ENT, 2023
Objective: Treatment for acute invasive fungal rhinosinusitis consists of systemic antifungal therapy, early and aggressive surgical debridement, and reversal of immunosuppression.
M. De Kezel, T. Van Zele, V. Ninclaus, M. Coppens   +3 more
doaj   +2 more sources

The direct costs of treating human visceral leishmaniasis in Brazil

Revista da Sociedade Brasileira de Medicina Tropical
INTRODUCTION: The drugs available for visceral leishmaniasis (VL) treatment in Brazil have specific characteristics in terms of operability, effectiveness, toxicity, and cost.
Tália Santana Machado de Assis, Dian Carlos Pinheiro Rosa, Eliane de Morais Teixeira, Gláucia Cota, André Luís Ferreira Azeredo-da-Silva, Guilherme Werneck, Ana Rabello   +6 more
doaj   +1 more source

Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

Infection and Drug Resistance, 2012
Marisa H Miceli1, Pranatharthi Chandrasekar21Oakwood Hospital and Medical Center, Dearborn, 2Division of Infectious Diseases, Wayne State University School of Medicine, Detroit, MI, USAAbstract: Liposomal amphotericin B is a "true&quot ...
Miceli MH, Chandrasekar P
doaj  

Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case

Revista da Sociedade Brasileira de Medicina Tropical
Visceral leishmaniasis is a systemic disease that is potentially severe and endemic in Brazil. It clinically manifests as fever, weight loss, swelling, hepatosplenomegaly, paleness, and edema.
Maria Antonia Ferreira Gomes, Lana Lira Cantidio de Medeiros, Fernanda Paula Dantas Lobo, Nathália Rayane Silva Wanderley, Ana Paula Rodrigues Matos, Tácito do Nascimento Jácome, Maria Goretti Lins Monteiro, Kleber Giovanni Luz   +7 more
doaj   +1 more source

Amphotericin-B/amphotericin-B-liposomal [PDF]

Reactions Weekly, 2022
openaire   +1 more source

Reworking the treatment of Indian Post kala-azar dermal leishmaniasis: A two-step therapy

Journal of Vector Borne Diseases
In the current scenario, treatment of Post kala-azar dermal leishmaniasis (PKDL) is intravenous liposomal amphotericin B or oral miltefosine. Over the years, there has been a gradual decline in the efficacy of miltefosine and a rise in permanent loss of ...
Sushruta Kathuria, Yugansh Gautam, Niti Khunger, Shruti Sharma, Ruchi Singh   +4 more
doaj   +1 more source

ENDEMIC MYCOSES PROGRAM IN THE BRAZILIAN UNIFIED HEALTH SYSTEM (SUS): CASE CHARACTERIZATION AND PHARMACOECONOMIC IMPACT IN A HIGH-COMPLEXITY UNIVERSITY HOSPITAL

Brazilian Journal of Infectious Diseases
Introduction/Objectives: The Ministry of Health Endemic Mycoses Program is essential in SUS, ensuring access to high-cost antifungals for patients with systemic fungal infections, according to RENAME and Clinical Protocols and Therapeutic Guidelines ...
Andressa Barros, Gilian Batista Balbueno Guerreiro, Maitê Roxo dos Santos, Lucia Collares Meirelles   +3 more
doaj   +1 more source